Detalles de la búsqueda
1.
Flow minimal residual disease monitoring of candidate leukemic stem cells defined by the immunophenotype, CD34+CD38lowCD19+ in B-lineage childhood acute lymphoblastic leukemia.
Haematologica;
95(4): 679-83, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19951974
2.
Establishment and validation of a standard protocol for the detection of minimal residual disease in B lineage childhood acute lymphoblastic leukemia by flow cytometry in a multi-center setting.
Haematologica;
94(6): 870-4, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19377076
3.
Analysis of early disease response in childhood acute lymphoblastic leukaemia: can peripheral blood replace bone marrow analysis?
Br J Haematol;
161(5): 743-745, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23496260
4.
Predictive value of flow cytometric minimal residual disease analysis in childhood acute lymphoblastic leukaemia at the end of remission induction therapy: results from a single UK centre.
Br J Haematol;
144(1): 133-5, 2009 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-19016737
Resultados
1 -
4
de 4
1
Próxima >
>>